Abstract:ObjectiveTo construct a recombinant Listeria ivanovii (LI) strain that expressed Mycobacterium tuberculosis (MTB) specific antigen protein as a novel multistage tuberculosis (TB) vaccine candidate, and evaluate the biosafety and immunogenicity in mouse model.MethodsT cell epitopes of four genes related to different stages of MTB infection were fused in series to form an antigen gene, i.e. the multistage antigen gene (named msv). Then msv was inserted into the targeting plasmid that contained LI homologous sequences. Recombinant LI strain was obtained by transfecting LI with targeting plasmid and screening the recombinant LI strain that carried msv in the genome after series of homologous gene recombination processes. The growth rate of the recombinant LI strain in vitro was observed and the expression of target protein was verified by Western blot. The 50% lethal dose (LD 50) of the recombinant strain to C57BL/6 mice was measured. Mice were intravenously inoculated with vaccine candidate in dose of 0.1×LD 50.The serum alanine aminotransferase (ALT) levels, bacterial load in organs, and organ pathological sections before and 1, 2, 3, 5, 7, 14 d after vaccination were used to evaluate the safety of vaccine candidate strain. To analyze the immunogenicity of vaccine candidate strain, mice were intravenously inoculated with LI- msv, LI, and NS respectively. Nine days post immunization, the spleens were isolated under sterile conditions and splenocytes were collected and stimulated. Lyphocytes which secret specific cytokines, interferon (IFN)-γ, tumor necrosis factor (TNF)-α and interleukin (IL)-2 were analyzed by flow cytometry.ResultsA recombinant strain named LI- msv which was capable of expressing the multistage TB antigen protein was successfully constructed. The LD 50 value of LI- msv for C57BL/6 mice (i.v.) was 3.3×10 8 CFU. After intravenously immunized the mice, this strain mainly multiplied in the liver and spleen, and was cleared at 7 d post innoculation. Such infection process caused transient pathological damages of the liver and spleen. Results of flow cytometry showed specific IFN-γ + CD4 + and IFN-γ + CD8 +T lymphocytes were successfully induced in LI -msv immunized mice spleen lymphocytes. The frequency of IFN-γ positive CD4 + and CD8 +T cells was significantly higher than those of vector control group and NS control group ( P<0.005). Additionally, the frequency of specific TNF-α + CD4 + T cell in LI -msv immunized group was significantly higher than that of vector control ( P<0.01) and NS control group ( P<0.005), and TNF-α + CD8 + T cell frequency obviously increased than NS control group ( P<0.005).ConclusionsA novel multistage TB vaccine candidate expressing TB multistage antigen based on LI was successfully constructed. This vaccine candidate is safe and can induce specific cellular immune response to some extent. It is promising to be further studied as a candidate vaccine against tuberculosis.

Construction of recombinant Lactococcus expressing thymosin and interferon fusion protein and its application as an immune adjuvant

[Construction and Evaluation of a Tuberculosis Multistage Vaccine Candidate Based on Recombinant Listeria Ivanovii].

[Expression, Purification and Identification of Fusion Protein Mtslpr-Ig].

[Construction and application of prokaryotic expression system of Leptospira interrogans lipL32/1-lipL41/1 fusion gene].

Construction of Prokaryotic Expression System of Ltb-Ureb Fusion Gene and Identification of the Recombinant Protein Immunity and Adjuvanticity

[Eukaryotic Expression of Leptospira Interrogans Lipl32/1-Ompl1/1 Fusion Gene Encoding Genus-Specific Protein Antigens and the Immunoreactivity of Expression Products].

Construction of a Recombinant Adenovirus Vector Expressing IL-18BP/IL-4 Fusion Gene and the Anti-Inflammatory Effect Induced by This Gene on Lipopolysaccharide-Stimulated Synovial Fibroblasts

Determination of fbe mucosal immunoadjuvantivity of recombinant EschericMa cott LTKA63 mutant and LTB

[Construction and identification of the prokaryotic expression system of rLTB/rCTB-rOmpL1/1 fusion genes].

Construction of a fusion gene encoding h1a-spaO of Salmonella paratyphi A and analysis of immuno-protective effects of the recombinant protein

Immunoprotection of Recombinant Antigen LTB-UreB-HpaA in Helicobacter Pylori Infected Mice and Immunoenhancement of the Inner Adjuvant LTB

Construction, Expression and Characterization of Human Interferon Α2b-（G4s）n-thymosin Α1 Fusion Proteins in Pichia Pastoris

Construction and immune efficacy of recombinant Lactobacillus casei expressing OmpAI of Aeromonas veronii C5–I as molecular adjuvant

Prokaryotic Expression of Trigeminy Artificial Fusion Gene of Leptospira Interrogans and the Immunogenicity of Its Products

Construction of Recombinant Lactococcus Lactis Vector Expressing HA1 Gene of Avian Influenza Virus and Application in Preventing Avian Influenza Virus

Construction of A Food-Grade Cell Surface Display System for Lactobacillus Casei

[Construction of Prokaryotic Expression Vector for Ag85A-HA2 Fusion Gene and Studies on the Immunity Efficacy of Fusion Protein Against Influenza A Virus].

Molecular Design and Characterization of Recombinant Fusion Protein of Human IFNα2a-THYα1

[Construction and Expression of Humanized Anti-Hbsag Scfv Targeting Interferon-Alpha in Escherichia Coli].

The Expression of Fusion Protein Hcgβ-C3d3 in Lactobacillus

Construction and expression of Mycobacterium tuberculosis fusion protein SHR3 and its immunogenicity analysis in combination with various adjuvants